loading page

Two Erigeron Species Comparison Based on Their Ingredients Profile by UPLC-PDA-QTOF/MS/MS and Discriminant Analysis
  • +3
  • Jianguang Zhang,
  • Yue Wang,
  • Jiangsang Wulu,
  • Wenfang Jin,
  • Qing Yang,
  • Zhifeng Zhang
Jianguang Zhang
Qinzhou Provincial Health School
Author Profile
Yue Wang
Southwest Minzu University
Author Profile
Jiangsang Wulu
Southwest Minzu University
Author Profile
Wenfang Jin
Southwest Minzu University
Author Profile
Qing Yang
Southwest Minzu University
Author Profile
Zhifeng Zhang
Southwest Minzu University

Corresponding Author:[email protected]

Author Profile

Abstract

Rationale: Erigeron breviscapus (EB)and Erigeron multiradiatus (EM) are the two species of the genus Erigeron (Asteraceae) with extremely close genetic relationships. They were used as the same “meiduoluomi” for the treatment of plague and epidemics in traditional Tibetan medicine. But in traditional Chinese medicine, only EB is used for treatment of cerebrovascular obstruction, hemiplegia due to stroke, coronary artery obstruction, chest congestion, angina pectoris. These two Erigeron species show different effects in different traditional medicines system. Therefore, analyzing the chemical compositions of two species will not only enhance comprehension of their medicinal properties, but also foster the advancement and exploration of novel applications. However, to date, there has been no comprehensive and detailed investigation comparing the constituents of EB and EM. Methods: A methodology for rapid identification of chemical profiles from two Erigeron species was devised through the integration of UHPLC-QTOF-MS/MS and multivariate statistical analysis. Additionally, a UHPLC-PDA method was established to precisely quantify of 11 components. Results: A total of 58 constituents comprising flavonoids, phenolics acids, saponin and long chain fatty acids were elucidated. Thirteen compounds were identified as potential differentiators in chemical profiles among the two Erigeron species. For quantitative assessment, 11 bioactive compounds were simultaneously quantified across 49 batches of Erigeron species samples utilizing UHPLC-PAD with wavelengths of 325 nm, 254 nm, and 266 nm. The method demonstrated excellent precision, linearity, accuracy, repeatability, stability, and recovery. Conclusions: The findings from this study will serve as a reference for quality control, functional activity exploration, and improved clinical application based on the ingredient profiles of the two species. Furthermore, this inaugural investigation into the ingredient profiles of these two species will enhance the potential and optimal utilization of both EB and EM resources.
23 Aug 2024Submitted to Rapid Communications in Mass Spectrometry
24 Aug 2024Submission Checks Completed
24 Aug 2024Assigned to Editor
24 Aug 2024Review(s) Completed, Editorial Evaluation Pending
25 Aug 2024Reviewer(s) Assigned
10 Sep 2024Editorial Decision: Revise Major
27 Sep 20241st Revision Received
27 Sep 2024Submission Checks Completed
27 Sep 2024Assigned to Editor
27 Sep 2024Review(s) Completed, Editorial Evaluation Pending
28 Sep 2024Reviewer(s) Assigned
06 Oct 2024Editorial Decision: Accept